Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Delaware News Ledger.
Press releases published on July 28, 2025
Aimfinity Investment Corp. I Announces New Monthly Extension for Business Combination
GlobeNewswire
·
July 28, 2025
Wilmington, DE, July 28, 2025 (GLOBE NEWSWIRE) -- Aimfinity Investment Corp. I (the “AIMA”) (Nasdaq: AIMTF), a special purpose acquisition company incorporated as a Cayman Islands exempted company, today announced that, in order to extend the date by which …
Questex’s Fierce Pharma Announces the 2025 Fierce Pharma Marketing Awards Finalists
GlobeNewswire
·
July 28, 2025
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Questex’s Fierce Pharma today announces the finalists for the Fierce Pharma Marketing Awards which honor leadership, vision, innovation and strategic accomplishments within the pharma marketing and advertising …
Staffbase announces integration with Google Workspace to enable more seamless internal communications for enterprises
GlobeNewswire
·
July 28, 2025
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Staffbase, the leading employee communications cloud platform, trusted by thousands of global organizations, today announced an integration with Google Workspace, reinforcing its commitment to delivering seamless …
Roadzen Announces Pricing of $2.25 Million Registered Direct Offering of Ordinary Shares
GlobeNewswire
·
July 28, 2025
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Roadzen Inc. (Nasdaq: RDZN) (“Roadzen” or the “Company”), a global leader in AI at the convergence of insurance and mobility, today announced that it has entered into a securities purchase agreement with an …
LOBO EV Technologies Ltd. and Strattners Exploring Strategic Investment Partnership
GlobeNewswire
·
July 28, 2025
WUXI, China, July 28, 2025 (GLOBE NEWSWIRE) -- LOBO EV Technologies Ltd. (Nasdaq: LOBO) (“LOBO” or the “Company”) today announced that it is currently in advanced negotiations with Strattners, a globally recognized financial group with historical roots …
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW251, a Novel Glypican 3-Targeted Topoisomerase 1 Inhibitor Antibody-Drug Conjugate
GlobeNewswire
·
July 28, 2025
Second antibody-drug conjugate (ADC) to progress into clinical development utilizing our proprietary payload and optimized antibody Preclinical results demonstrate strong anti-tumor activity and favorable tolerability profile Phase 1 clinical trial …